In this webinar Dr. César Evaristo will describe best practices for isolation of tumor infiltrating leukocytes (TILs) and present an optimized workflow for faster and improved flow analysis.
Webinar attendees will learn about innovative tools and solutions to increase quality of data, reduce experimental time, and ease scale-up during TIL analysis using flow cytometry. They will find out about optimized workflows for the isolation and flow cytometric phenotyping of mouse TILs, and methods to reduce biases during TIL analysis.
Recent advances in immuno-oncology research have demonstrated the critical role of immune cells in cancer therapy. A deep understanding of the interactions and phenotypes of immune and tumor cells within the tumor microenvironment is therefore key to developing future immune-based cancer therapy strategies. However, dissociation of solid tumor samples prior to their use in downstream applications, such as immunomagnetic enrichment, flow cytometry, and single-cell sequencing, can be challenging. In addition, tumor cells often cause background signal and introduce bias to the analysis of immune cells, further complicating TIL research.
Dr. César Evaristo, who received his doctorate from the University of Paris Descartes, will present the webinar. After seven years as a research scientist in the United States and Germany, he joined Miltenyi Biotec in 2016 as a team coordinator of the Tumor Immunology Group. He focuses on immuno-oncology preclinical research, target discovery, as well as oncology-related product development.
Find more Miltenyi Biotec webinars at https://www.miltenyibiotec.com/macs-academy
ABOUT MILTENYI BIOTEC
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company’s innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Miltenyi Biotec’s technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Their more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In their commitment to the scientific community, Miltenyi Biotec also offers comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 2,000 employees in 25 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.